| Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis EE Gardner, BH Lok, VE Schneeberger, P Desmeules, LA Miles, ... Cancer cell 31 (2), 286-299, 2017 | 478 | 2017 |
| PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer BH Lok, EE Gardner, VE Schneeberger, A Ni, P Desmeules, N Rekhtman, ... Clinical Cancer Research 23 (2), 523-535, 2017 | 332 | 2017 |
| Preclinical modeling of KIF5B–RET fusion lung adenocarcinoma Q Huang, VE Schneeberger, N Luetteke, C Jin, R Afzal, MM Budzevich, ... Molecular cancer therapeutics 15 (10), 2521-2529, 2016 | 78 | 2016 |
| Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma VE Schneeberger, Y Ren, N Luetteke, Q Huang, L Chen, HR Lawrence, ... Oncotarget 6 (8), 6191, 2015 | 63 | 2015 |
| Quantitation of murine stroma and selective purification of the human tumor component of patient-derived xenografts for genomic analysis VE Schneeberger, V Allaj, EE Gardner, JT Poirier, CM Rudin PloS one 11 (9), e0160587, 2016 | 55 | 2016 |
| SHP2E76K mutant promotes lung tumorigenesis in transgenic mice VE Schneeberger, N Luetteke, Y Ren, H Berns, L Chen, P Foroutan, ... Carcinogenesis 35 (8), 1717-1725, 2014 | 46 | 2014 |
| Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2 H Win-Piazza, VE Schneeberger, L Chen, D Pernazza, HR Lawrence, ... Cancer letters 320 (1), 81-85, 2012 | 19 | 2012 |
| Novel Roles of the Protein Tyrosine Phosphatase SHP2 in Non-small Cell Lung Cancer VE Schneeberger University of South Florida, 2014 | 1 | 2014 |
| Characteristics, oncogene dependency, and response to ponatinib of a novel transgenic mouse model of KIF5B-RET-induced lung adenocarcinoma Q Huang, VE Schneeberger, N Luetteke, R Afzal, MM Budzevich, ... Journal of Thoracic Oncology 11 (2), S54, 2016 | | 2016 |
